Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response

References

• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–944. doi:10.1161/CIR.0b013e31820a55f521262990
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–457. doi:10.1056/NEJMra120153423902484
   PubMed Web of Science ®Google Scholar
• Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341–355. doi:10.1016/j.cell.2011.04.00521529710
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473(7347):317–325. doi:10.1038/nature1014621593864
   PubMed Web of Science ®Google Scholar
• Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 2007;116(16):1832–1844. doi:10.1161/CIRCULATIONAHA.106.67689017938300
   PubMed Web of Science ®Google Scholar
• Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–1866. doi:10.1161/CIRCRESAHA.114.30272124902970
   PubMed Web of Science ®Google Scholar
• Park S, Lakatta EG. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J. 2012;53(2):258–261. doi:10.3349/ymj.2012.53.2.25822318811
   PubMed Web of Science ®Google Scholar
• Conti P, Shaik-Dasthagirisaeb Y. Atherosclerosis: a chronic inflammatory disease mediated by mast cells. Cent Eur J Immunol. 2015;40(3):380–386.26648785
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320(14):915–924. doi:10.1056/NEJM1989040632014072648148
   PubMed Web of Science ®Google Scholar
• Moore KJ, Freeman MW. Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol. 2006;26(8):1702–1711. doi:10.1161/01.ATV.0000229218.97976.4316728653
   PubMed Web of Science ®Google Scholar
• Shi Y, Cosentino F, Camici GG, et al. Oxidized low-density lipoprotein activates p66Shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-beta, and c-Jun N-terminal kinase kinase in human endothelial cells. Arterioscler Thromb Vasc Biol. 2011;31(9):2090–2097. doi:10.1161/ATVBAHA.111.22926021817106
   PubMed Web of Science ®Google Scholar
• Imran M, Rauf A, Abu-Izneid T, et al. Luteolin, a flavonoid, as an anticancer agent: a review. Biomed Pharmacother. 2019;112:108612. doi:10.1016/j.biopha.2019.10861230798142
   PubMed Web of Science ®Google Scholar
• Yang PW, Lu ZY, Pan Q, et al. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1. Phytomedicine. 2018;57:18–29. doi:10.1016/j.phymed.2018.10.02730668319
   PubMed Web of Science ®Google Scholar
• Fei J, Liang B, Jiang C, Ni H, Wang L. Luteolin inhibits IL-1beta-induced in fl ammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model. Biomed Pharmacother. 2019;109:1586–1592. doi:10.1016/j.biopha.2018.09.16130551412
   PubMed Web of Science ®Google Scholar
• Hoult JR, Paya M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol. 1996;27(4):713–722. doi:10.1016/0306-3623(95)02112-48853310
   PubMedGoogle Scholar
• Fan X, Du K, Li N, et al. Evaluation of anti-nociceptive and anti-inflammatory effect of luteolin in Mice. J Environ Pathol Toxicol Oncol. 2018;37(4):351–364. doi:10.1615/JEnvironPatholToxicolOncol.201802766630806241
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu P, Yu H, Shi L. Luteolin protects PC-12 cells from H2O2-induced injury by up-regulation of microRNA-21. Biomed Pharmacother. 2019;112:108698. doi:10.1016/j.biopha.2019.10869830802826
   PubMed Web of Science ®Google Scholar
• Yin H, Wang L, Wu M, Liu Y, Li N, Chen T. Cyanidin-3-O-glucoside chloride acts synergistically with luteolin to inhibit the growth of colon and breast carcinoma cells. Pharmazie. 2019;74(1):54–61. doi:10.1691/ph.2019.874630782251
   PubMed Web of Science ®Google Scholar
• Wang L, Huang Z, Huang W, et al. Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress. Sci Rep. 2017;8:45917. doi:10.1038/srep4591728374780
   PubMed Web of Science ®Google Scholar
• Becker S, Groner B, Muller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature. 1998;394(6689):145–151. doi:10.1038/281019671298
   PubMed Web of Science ®Google Scholar
• Li H, Liu A, Zhao Z, et al. Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3). J Med Chem. 2011;54(15):5592–5596. doi:10.1021/jm101330h21678971
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang L, Deng Y, et al. Fraxetin suppresses proliferation of non-small-cell lung cancer cells via preventing activation of signal transducer and activator of transcription 3. Tohoku J Exp Med. 2019;248(1):3–12. doi:10.1620/tjem.248.331080186
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, et al. UCSF chimera–a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605–1612. doi:10.1002/jcc.2008415264254
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–2791. doi:10.1002/jcc.2125619399780
   PubMed Web of Science ®Google Scholar
• Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput. 2015;11(8):3696–3713. doi:10.1021/acs.jctc.5b0025526574453
   PubMed Web of Science ®Google Scholar
• Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. Development and testing of a general amber force field. J Comput Chem. 2004;25(9):1157–1174. doi:10.1002/jcc.2003515116359
   PubMed Web of Science ®Google Scholar
• Loncharich RJ, Brooks BR, Pastor RW. Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N’-methylamide. Biopolymers. 1992;32(5):523–535. doi:10.1002/bip.3603205081515543
   PubMed Web of Science ®Google Scholar
• Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR. Molecular-dynamics with coupling to an external bath. J Chem Phys. 1984;81(8):3684–3690. doi:10.1063/1.448118
   Web of Science ®Google Scholar
• Roe DR, Cheatham TE 3rd. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput. 2013;9(7):3084–3095. doi:10.1021/ct400341p26583988
   PubMed Web of Science ®Google Scholar
• Miller BR, McGee TD, Swails JM, Homeyer N, Gohlke H, Roitberg AE. MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput. 2012;8(9):3314–3321. doi:10.1021/ct300418h26605738
   PubMed Web of Science ®Google Scholar
• Ying Y, Jin J, Ye L, Sun P, Wang H, Wang X. Phloretin prevents diabetic cardiomyopathy by dissociating keap1/Nrf2 complex and inhibiting oxidative stress. Front Endocrinol (Lausanne). 2018;9:774. doi:10.3389/fendo.2018.0042030619098
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhao J, Song X, et al. Amygdalin reduces lipopolysaccharide-induced chronic liver injury in rats by down-regulating PI3K/AKT, JAK2/STAT3 and NF-kappaB signalling pathways. Artif Cells Nanomed Biotechnol. 2019;47(1):2688–2697. doi:10.1080/21691401.2019.163408431257932
   PubMed Web of Science ®Google Scholar
• Zhang H, Sha J, Feng X, et al. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3beta/STAT3-NF-kappaB signaling pathway in rats. Int Immunopharmacol. 2019;74:105717. doi:10.1016/j.intimp.2019.10571731254953
   PubMed Web of Science ®Google Scholar
• Chen J, Zhang W, Xu Q, et al. Ang-(1–7) protects HUVECs from high glucose-induced injury and inflammation via inhibition of the JAK2/STAT3 pathway. Int J Mol Med. 2018;41(5):2865–2878. doi:10.3892/ijmm.2018.350729484371
   PubMed Web of Science ®Google Scholar
• Qin Z, Bagley J, Sukhova G, et al. Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3. J Mol Cell Cardiol. 2015;87:160–170. doi:10.1016/j.yjmcc.2015.08.01426299839
   PubMed Web of Science ®Google Scholar
• Maziere C, Conte MA, Maziere JC. Activation of JAK2 by the oxidative stress generated with oxidized low-density lipoprotein. Free Radic Biol Med. 2001;31(11):1334–1340. doi:10.1016/S0891-5849(01)00649-911728804
   PubMed Web of Science ®Google Scholar
• Cummins CB, Wang X, Nunez Lopez O, et al. Luteolin-mediated inhibition of hepatic stellate cell activation via suppression of the STAT3 pathway. Int J Mol Sci. 2018;19(6):1567. doi:10.3390/ijms19061567
   PubMed Web of Science ®Google Scholar
• Sonoki H, Tanimae A, Endo S, et al. Kaempherol and luteolin decrease claudin-2 expression mediated by inhibition of STAT3 in lung adenocarcinoma A549 cells. Nutrients. 2017;9(6):597. doi:10.3390/nu9060597
   PubMed Web of Science ®Google Scholar
• Palombo R, Savini I, Avigliano L, et al. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model. Cell Death Dis. 2016;7(8):e2344. doi:10.1038/cddis.2016.20127537526
   PubMed Web of Science ®Google Scholar
• Xiao H, Bid HK, Jou D, et al. A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells. J Biol Chem. 2015;290(6):3418–3429. doi:10.1074/jbc.M114.61674825313399
   PubMed Web of Science ®Google Scholar
• Hao L, Zhu G, Lu Y, et al. Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role. FEBS Lett. 2015;589(12):1331–1339. doi:10.1016/j.febslet.2015.04.00825896020
   PubMed Web of Science ®Google Scholar
• Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12(3):204–212. doi:10.1038/ni.200121321594
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart. 2004;90(12):1385–1391. doi:10.1136/hrt.2004.04179815547008
   PubMed Web of Science ®Google Scholar
• Rosenfeld ME. Inflammation and atherosclerosis: direct versus indirect mechanisms. Curr Opin Pharmacol. 2013;13(2):154–160. doi:10.1016/j.coph.2013.01.00323357128
   PubMed Web of Science ®Google Scholar